X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8438) 8438
Dissertation (19) 19
Book Chapter (15) 15
Publication (10) 10
Magazine Article (6) 6
Conference Proceeding (4) 4
Web Resource (4) 4
Journal / eJournal (2) 2
Book / eBook (1) 1
Book Review (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5056) 5056
serogroup (4316) 4316
animals (2418) 2418
microbiology (2361) 2361
infectious diseases (2223) 2223
female (2105) 2105
immunology (2052) 2052
male (1890) 1890
vaccines (1406) 1406
epidemiology (1326) 1326
infant (1285) 1285
adult (1278) 1278
child (1259) 1259
adolescent (1238) 1238
child, preschool (1216) 1216
disease (1173) 1173
meningitis (1069) 1069
neisseria meningitidis (1034) 1034
vaccination (980) 980
analysis (857) 857
middle aged (843) 843
serotyping (843) 843
prevalence (830) 830
research (828) 828
children (825) 825
identification (816) 816
young adult (784) 784
meningococcal vaccines - immunology (770) 770
virulence (758) 758
neisseria-meningitidis (754) 754
immunization (751) 751
strains (748) 748
infections (726) 726
phylogeny (721) 721
bacteria (710) 710
health aspects (677) 677
serotypes (675) 675
genotype (672) 672
medicine, research & experimental (667) 667
aged (640) 640
immunogenicity (640) 640
serogroups (632) 632
infection (619) 619
mice (618) 618
veterinary sciences (616) 616
antigens (615) 615
vaccine (615) 615
biotechnology & applied microbiology (610) 610
meningococcal infections - prevention & control (599) 599
meningococcal disease (582) 582
medicine (577) 577
proteins (574) 574
antibodies, bacterial - blood (561) 561
research article (530) 530
meningococcal infections - epidemiology (528) 528
meningococcal vaccines - administration & dosage (528) 528
public health (523) 523
polymerase chain reaction (506) 506
molecular sequence data (503) 503
antibodies (500) 500
united-states (489) 489
meningococcal infections - microbiology (488) 488
surveillance (487) 487
disease outbreaks (485) 485
epidemics (482) 482
cattle (481) 481
salmonella (481) 481
outbreak (471) 471
virology (468) 468
infant, newborn (456) 456
incidence (451) 451
conjugate vaccine (450) 450
anti-bacterial agents - pharmacology (441) 441
neisseria meningitidis - genetics (429) 429
microbial sensitivity tests (426) 426
genetic aspects (419) 419
neisseria meningitidis, serogroup b - immunology (416) 416
streptococcus pneumoniae (413) 413
escherichia coli (412) 412
risk factors (409) 409
neisseria meningitidis - immunology (405) 405
meningitis, meningococcal - epidemiology (402) 402
viruses (402) 402
bacterial proteins - genetics (399) 399
sequence analysis, dna (397) 397
meningitis, meningococcal - prevention & control (395) 395
pneumonia (393) 393
public, environmental & occupational health (393) 393
genes (392) 392
carriage (389) 389
multidisciplinary sciences (389) 389
streptococcus pneumoniae - classification (384) 384
allergy and immunology (375) 375
serogroup-b (372) 372
antigens, bacterial - immunology (359) 359
neisseria meningitidis - classification (350) 350
pediatrics (350) 350
vaccines, conjugate - immunology (350) 350
pathogens (349) 349
prevention (349) 349
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8065) 8065
French (158) 158
Spanish (106) 106
Japanese (93) 93
Portuguese (87) 87
Russian (70) 70
Chinese (51) 51
German (43) 43
Norwegian (13) 13
Polish (12) 12
Korean (9) 9
Turkish (9) 9
Czech (8) 8
Hungarian (7) 7
Italian (6) 6
Dutch (5) 5
Danish (3) 3
Persian (2) 2
Romanian (2) 2
Catalan (1) 1
Greek (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of infection, ISSN 0163-4453, 2015, Volume 71, Issue 5, pp. 544 - 552
Summary Objectives Neisseria meningitidis is a leading cause of meningitis and septicaemia. The hyperinvasive ST-11 clonal complex (cc11) caused serogroup C... 
Infectious Disease | Meningococcal | Serogroup C | Genome | ST-11 clonal complex | Serogroup W | INFECTIOUS DISEASES | CLONAL COMPLEX | NEISSERIA-MENINGITIDIS | VACCINE | ET-15 CLONE | EMERGENCE | W135 | DISEASE | OUTBREAK | ET-37/ST-11 | STRAIN | Meningococcal Infections - epidemiology | Humans | Male | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Phylogeny | Multilocus Sequence Typing | Neisseria meningitidis, Serogroup B - isolation & purification | Endemic Diseases | South America - epidemiology | Homosexuality, Male | Disease Outbreaks | Neisseria meningitidis, Serogroup C - classification | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | France - epidemiology | Neisseria meningitidis, Serogroup C - genetics | South Africa - epidemiology | Serogroup | Neisseria meningitidis - isolation & purification | Neisseria meningitidis - classification | Neisseria meningitidis, Serogroup B - classification | North America - epidemiology | United Kingdom - epidemiology | Music in education | Epidemics | Respiratory tract diseases | Meningitis | Health aspects | South America | Biochemistry, Molecular Biology | Genomics | United Kingdom | Neisseria meningitidis | North America | Life Sciences | Neisseria meningitidis, Serogroup C | South Africa | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup B | France | Meningococcal Infections
Journal Article
1995, ISBN 0471952591, cm.
Book
Emerging infectious diseases, ISSN 1080-6059, 2016, Volume 22, Issue 10, pp. 1762 - 1768
In 2015, Niger reported the largest epidemic of Neisseria meningitidis serogroup C (NmC) meningitis in sub-Saharan Africa. The NmC epidemic coincided with... 
AFRICA | INFECTIOUS DISEASES | CARRIAGE | BURKINA-FASO | W135 | MENINGOCOCCAL MENINGITIS | H BINDING-PROTEIN | DISEASE | VACCINE | SUSCEPTIBILITY | DIVERSITY | IMMUNOLOGY | Communicable Diseases, Emerging | Epidemics | Genome, Bacterial | Neisseria meningitidis, Serogroup C - genetics | Niger - epidemiology | Humans | Phylogeny | Antigens, Bacterial - genetics | Neisseria meningitidis - isolation & purification | Sequence Analysis, DNA | Meningitis, Meningococcal - epidemiology | Molecular Typing | DNA, Bacterial | Genetic Variation | Meningitis, Meningococcal - microbiology | Neisseria meningitidis - genetics | Drug Resistance, Bacterial - genetics | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | Neisseria meningitidis/genetics | Neisseria meningitidis, Serogroup C/genetics | Life Sciences | Neisseria meningitidis/isolation & purification | Genetics | Antigens, Bacterial/genetics | Meningitis, Meningococcal/epidemiology | Meningitis, Meningococcal/microbiology | Bacteriology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Niger/epidemiology | Neisseria meningitidis, Serogroup C/isolation & purification | Drug Resistance, Bacterial/genetics | Santé publique et épidémiologie | Neisseria meningitidis serogroup C | meningitis belt | bacteria | Niger | whole-genome sequencing | Research | Serogroup C and Resurging Serogroup W, Niger, 2015 | Whole-Genome Characterization of Epidemic | Meningococcal meningitis
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 416 - 425
Summary Background A novel multicomponent vaccine against meningococcal capsular group B (MenB) disease contains four major components: factor-H-binding... 
Infectious Disease | ANTIBODIES | INFECTIOUS DISEASES | IMMUNOGENICITY | SEROGROUP-B VACCINE | PROTEIN | NADA | TOLERABILITY | NEISSERIA-MENINGITIDIS | SURVEILLANCE | DIVERSITY | RANDOMIZED CONTROLLED-TRIAL | Geography | Genes, Bacterial | Predictive Value of Tests | Meningococcal Vaccines - therapeutic use | Reproducibility of Results | Enzyme-Linked Immunosorbent Assay | Humans | Europe - epidemiology | Genotype | Neisseria meningitidis, Serogroup B - genetics | Adhesins, Bacterial - analysis | Antigens, Bacterial - genetics | Bacterial Typing Techniques - methods | Neisseria meningitidis, Serogroup B - isolation & purification | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - prevention & control | Multilocus Sequence Typing - methods | Meningitis, Meningococcal - microbiology | Neisseria meningitidis, Serogroup B - classification | DNA, Bacterial - analysis | Neisseria meningitidis, Serogroup B - pathogenicity | Population Surveillance - methods | Medical research | Glycosaminoglycans | Media coverage | Medicine, Experimental | Anticoagulants (Medicine) | Vaccines | Public health | Protein binding | Europe | Antigens, Bacterial | Meningococcal Vaccines | Adhesins, Bacterial | Multilocus Sequence Typing | DNA, Bacterial | Meningitis, Meningococcal | Life Sciences | Human health and pathology | Infectious diseases | Bacterial Typing Techniques | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup B | Population Surveillance
Journal Article
The Journal of infection, ISSN 0163-4453, 2017, Volume 74, Issue 6, pp. 564 - 574
Summary Objectives This work aimed to describe the epidemiology of invasive meningococcal disease (IMD) in France, 2006–2015, including group- and... 
Infectious Disease | Invasive meningococcal disease | Neisseria meningitidis | Meningococcal C conjugate vaccination | France | Epidemiology | INFECTIOUS DISEASES | CLONAL COMPLEX | CARRIAGE | NEISSERIA-MENINGITIDIS | VACCINATION | SEROGROUP | CHILDREN | PCR-BASED IDENTIFICATION | HERD-IMMUNITY | ASSOCIATION | VACCINES | Meningococcal Infections - epidemiology | Meningococcal Infections - mortality | Humans | Middle Aged | Child, Preschool | Cost of Illness | Infant | Male | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup B - isolation & purification | Incidence | Young Adult | Adult | Female | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup B - pathogenicity | Child | Neisseria meningitidis - pathogenicity | France - epidemiology | Genotype | Neisseria meningitidis - isolation & purification | Epidemics - statistics & numerical data | Vaccination - statistics & numerical data | Adolescent | Epidemics - prevention & control | Aged | Meningococcal Vaccines - administration & dosage | Meningitis | Vaccination | Genomics | Meningococcal Vaccines/administration & dosage | Neisseria meningitidis/genetics | France/epidemiology | Neisseria meningitidis, Serogroup B/genetics | Meningococcal Infections/mortality | Neisseria meningitidis, Serogroup B/pathogenicity | Life Sciences | Neisseria meningitidis/pathogenicity | Neisseria meningitidis/isolation & purification | Epidemics/statistics & numerical data | Meningococcal Infections/microbiology | Biochemistry, Molecular Biology | Human health and pathology | Vaccination/statistics & numerical data | Epidemics/prevention & control | Infectious diseases | Meningococcal Infections/epidemiology | Neisseria meningitidis, Serogroup B/isolation & purification | Santé publique et épidémiologie
Journal Article
PLoS medicine, ISSN 1549-1277, 2006, Volume 3, Issue 9, pp. 1579 - 1586
Background Outbreaks of meningococcal meningitis ( meningitis caused by Neisseria meningitidis) are a major public health concern in the African "meningitis... 
AFRICA | MEDICINE, GENERAL & INTERNAL | ASSAY | NIGER | W135 | MENINGOCOCCAL MENINGITIS | SEQUENCE | IDENTIFICATION | CONFIDENCE | PCR | Neisseria meningitidis, Serogroup A - immunology | Predictive Value of Tests | Africa - epidemiology | Neisseria meningitidis, Serogroup C - immunology | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Neisseria meningitidis, Serogroup Y - isolation & purification | Prospective Studies | Meningitis, Meningococcal - diagnosis | Humans | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - immunology | Polymerase Chain Reaction - methods | Likelihood Functions | Time Factors | Sensitivity and Specificity | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | Reproducibility of Results | Chromatography - methods | Antibodies, Monoclonal | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup A - isolation & purification | Neisseria meningitidis, Serogroup W-135 - immunology | Reagent Kits, Diagnostic | Meningitis, Meningococcal - cerebrospinal fluid | Evaluation Studies as Topic | Causes of | Medical tests | Neisseria meningitidis | Diagnosis | Health aspects | Bioengineering | Neisseria menin | Africa | Chromatography | Meningitis, Meningococcal | Neisseria meningitidis, Serogroup W-135 | Life Sciences | Human health and pathology | Infectious diseases | Immunology | Neisseria meningitidis, Serogroup C | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup A | Evaluation Studies | Biotechnology | Public Health | Microbiology | Medicine in Developing Countries | Infectious Diseases | Vaccines | Primary Care | Epidemiology
Journal Article
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 02/2016, Volume 291, Issue 7, pp. 3224 - 3238
The degree of phosphorylation and phosphoethanolaminylation of lipid A on neisserial lipooligosaccharide (LOS), a major cell-surface antigen, can be correlated... 
infection | lipid A | phosphoethanolamine | ALKALINE-PHOSPHATASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | NORMAL HUMAN SERUM | SEROGROUP-B | Neisseria meningitidis | acylation | INNER-CORE | LACTO-N-NEOTETRAOSE | GRAM-NEGATIVE BACTERIA | FACTOR-H BINDING | sialic acid | LIPID-A | bioinformatics | ENDOTOXIN TOLERANCE | phosphorylation | MENINGOCOCCAL DISEASE | lipooligosaccharide | mass spectrometry (MS) | Meningococcal Infections - immunology | Tumor Necrosis Factor-alpha - metabolism | Carrier State - blood | Neisseria meningitidis, Serogroup C - immunology | Phosphorylation | Humans | Virulence | Neisseria meningitidis, Serogroup B - immunology | Carrier State - microbiology | Monocytes - metabolism | Gene Expression Profiling | Monocytes - immunology | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup B - metabolism | Antigens, Bacterial - biosynthesis | Meningitis, Meningococcal - immunology | Neisseria meningitidis, Serogroup C - metabolism | Meningitis, Meningococcal - microbiology | Neisseria meningitidis, Serogroup C - classification | Carrier State - cerebrospinal fluid | Molecular Structure | Neisseria meningitidis, Serogroup B - pathogenicity | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Antigens, Bacterial - toxicity | Acylation | Carrier State - immunology | Sepsis - immunology | Antigens, Bacterial - chemistry | Lipopolysaccharides - toxicity | Immunity, Innate - drug effects | Computational Biology | Meningitis, Meningococcal - blood | Neisseria meningitidis, Serogroup C - pathogenicity | Monocytes - drug effects | Sepsis - cerebrospinal fluid | Meningococcal Infections - cerebrospinal fluid | Norway | Adolescent | Lipopolysaccharides - biosynthesis | Cell Line, Tumor | Meningitis, Meningococcal - cerebrospinal fluid | Neisseria meningitidis, Serogroup B - classification | Lipopolysaccharides - chemistry | Sepsis - blood | Meningococcal Infections - blood | Sepsis - microbiology | Microbiology
Journal Article
Journal of clinical microbiology, ISSN 0095-1137, 2006, Volume 44, Issue 3, pp. 1127 - 1131
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
CARRIED MENINGOCOCCI | POPULATION BIOLOGY | SURVEILLANCE | MICROBIOLOGY | DIVERSITY | CHAIN-REACTION PCR | MENINGOCOCCAL DISEASE | NONCULTURE DIAGNOSIS | EXPRESSION | NULL LOCUS | EPIDEMIOLOGY | Humans | Neisseria meningitidis, Serogroup A - classification | Carrier State - microbiology | Neisseria meningitidis, Serogroup Y - genetics | DNA Primers - genetics | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup W-135 - pathogenicity | Serotyping - methods | Polymerase Chain Reaction - methods | Virulence - genetics | Neisseria meningitidis, Serogroup C - classification | Base Sequence | Neisseria meningitidis, Serogroup W-135 - classification | Sensitivity and Specificity | Neisseria meningitidis, Serogroup A - genetics | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup B - pathogenicity | Neisseria meningitidis, Serogroup Y - classification | Polymerase Chain Reaction - statistics & numerical data | Serotyping - statistics & numerical data | Neisseria meningitidis - pathogenicity | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Neisseria meningitidis, Serogroup C - pathogenicity | DNA, Bacterial - genetics | Neisseria meningitidis - classification | Neisseria meningitidis, Serogroup A - pathogenicity | Neisseria meningitidis, Serogroup B - classification | Neisseria meningitidis, Serogroup Y - pathogenicity | Bacteriology
Journal Article
Journal of Infection, ISSN 0163-4453, 2008, Volume 57, Issue 4, pp. 324 - 331
Summary Objectives The aim of this study was to characterize Neisseria meningitidis strains causing invasive disease in Rio Grande do Sul (RS), during... 
Infectious Disease | Hypervirulent lineages | PorA VR types | Neisseria meningitidis | Epidemiology | Serogroup B vaccine | UNITED-STATES | INFECTIOUS DISEASES | W135 MENINGOCOCCAL DISEASE | SEROGROUP-B | PREVENTION | PORA TYPES | IDENTIFICATION | SEROSUBTYPES | SURVEILLANCE | DIVERSITY | Meningococcal Infections - epidemiology | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Prevalence | Humans | Child, Preschool | Infant | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup B - isolation & purification | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - microbiology | Neisseria meningitidis, Serogroup C - classification | Bacterial Typing Techniques | Neisseria meningitidis, Serogroup W-135 - classification | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup C - isolation & purification | Brazil - epidemiology | Serotyping | Neisseria meningitidis - pathogenicity | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Porins - genetics | Neisseria meningitidis - isolation & purification | Sequence Analysis, DNA | DNA, Bacterial - genetics | Neisseria meningitidis - classification | Molecular Epidemiology | Neisseria meningitidis, Serogroup B - classification | Population Surveillance | Prevalence studies (Epidemiology)
Journal Article
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 07/2010, Volume 185, Issue 1, pp. 507 - 516
Properdin, a positive regulator of the alternative pathway (AP) of complement is important in innate immune defenses against invasive Neisserial infections.... 
C4B-BINDING PROTEIN | MOLECULAR-MECHANISM | SERUM RESISTANCE | FACTOR-H BINDING | COMPLEMENT DEFICIENCY STATES | SEROGROUP-B | HEREDITARY PROPERDIN | REGULATORY PROTEIN | FULMINANT MENINGOCOCCAL INFECTIONS | IMMUNOLOGY | CAPSULE NULL LOCUS | Neisseria meningitidis, Serogroup A - immunology | Neisseria meningitidis, Serogroup C - immunology | Humans | Neisseria meningitidis, Serogroup B - immunology | Neisseria meningitidis, Serogroup Y - genetics | Neisseria meningitidis, Serogroup B - genetics | Neisseria meningitidis, Serogroup B - metabolism | Neisseria meningitidis, Serogroup W-135 - metabolism | Neisseria meningitidis, Serogroup C - metabolism | Neisseria meningitidis, Serogroup A - metabolism | Neisseria meningitidis, Serogroup A - genetics | Neisseria gonorrhoeae - immunology | Complement Pathway, Alternative - genetics | Neisseria gonorrhoeae - genetics | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Bacterial Adhesion - immunology | Complement C3 - metabolism | Complement C3 Convertase, Alternative Pathway - metabolism | Properdin - physiology | Protein Binding - immunology | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup Y - metabolism | Neisseria meningitidis, Serogroup W-135 - immunology | Complement Pathway, Alternative - immunology | Enzyme Stability - immunology | Neisseria gonorrhoeae - metabolism | Properdin - isolation & purification | Properdin - metabolism
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 5/2009, Volume 199, Issue 9, pp. 1360 - 1368
Background. Meningococcal epidemics in Africa are generally caused by capsular group A strains, but W- 135 or X strains also cause epidemics in this region.... 
Epidemics | Antigens | Carrier proteins | Vaccination | Antibodies | Monoclonal antibodies | Amino acids | Bacteria | Neisseria meningitidis | Epidemiology | Meningococcal meningitis | IMMUNITY | INFECTIOUS DISEASES | BURKINA-FASO | NEISSERIA-MENINGITIDIS | MICROBIOLOGY | CANDIDATE | IMMUNOLOGY | IMMUNOGENICITY | BACTERICIDAL ACTIVITY | SEROGROUP-X | GROUP-B | MONOCLONAL-ANTIBODIES | MEMBRANE VESICLE VACCINE | Neisseria meningitidis - pathogenicity | Complement Factor H - immunology | Africa - epidemiology | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Neisseria meningitidis, Serogroup W-135 - genetics | Humans | Meningitis, Meningococcal - genetics | Complement System Proteins - immunology | Neisseria meningitidis - isolation & purification | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - immunology | Meningitis, Meningococcal - prevention & control | Neisseria meningitidis, Serogroup W-135 - pathogenicity | Epitopes - immunology | Neisseria meningitidis, Serogroup A - isolation & purification | Complement Factor H - metabolism | Neisseria meningitidis, Serogroup A - pathogenicity | Polymerase Chain Reaction | Neisseria meningitidis, Serogroup A - genetics | Antibodies, Bacterial - immunology | Bacterial Proteins - metabolism | Neisseria meningitidis - genetics | Epitopes - chemistry | Antigens, Bacterial - metabolism | Causes of | Physiological aspects | Genetic aspects | Research | Binding proteins | Gene expression | Meningococcal infections
Journal Article
Journal Article